β-Hydroxybutyrate elevation as a compensatory response against oxidative stress in cardiomyocytes

Biochemical and Biophysical Research Communications

Volumn 475, Issue 4, 2016, Pages 322-328

  Nagao, Manabu ^a   Toh, Ryuji ^a   Irino, Yasuhiro ^a   Mori, Takeshige ^a   Nakajima, Hideto ^a   Hara, Tetsuya ^a   Honjo, Tomoyuki ^a   Satomi Kobayashi, Seimi ^a   Shinke, Toshiro ^a   Tanaka, Hidekazu ^a   Ishida, Tatsuro ^a   Hirata, Ken ichi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Forkhead box O3a (FOXO3a); Heart failure; Oxidative stress; Succinyl CoA:3 oxoacid CoA transferase (SCOT); hydroxybutyrate

Indexed keywords

3 HYDROXYBUTYRIC ACID; 3 OXOACID COENZYME A TRANSFERASE; CATALASE; COENZYME A TRANSFERASE; FATTY ACID; HYDROETHIDINE; HYDROGEN PEROXIDE; KETONE BODY; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR FKHRL1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIAC MUSCLE CELL; CELL VIABILITY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENERGY METABOLISM; HEART FAILURE; HEART FUNCTION; HEART MUSCLE METABOLISM; HEART PROTECTION; KETOGENESIS; LIVER METABOLISM; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE; CELL CULTURE; METABOLISM; PATHOLOGY; RAT;

3-HYDROXYBUTYRIC ACID; ANIMALS; CELLS, CULTURED; COENZYME A-TRANSFERASES; HYDROGEN PEROXIDE; MALE; MICE, INBRED C57BL; MYOCARDIUM; MYOCYTES, CARDIAC; OXIDATIVE STRESS; RATS;

EID: 84970022005     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.05.097     Document Type: Article

References (35)

1. [1] Cotter, D.G., Schugar, R.C., Crawford, P.A., Ketone body metabolism and cardiovascular disease. Am. J. Physiol. Heart Circ. Physiol. 304 (2013), H1060–H1076.
2. [2] Lommi, J., Kupari, M., Koskinen, P., et al. Blood ketone bodies in congestive heart failure. J. Am. Coll. Cardiol. 28 (1996), 665–672.
3. [3] Opie, L.H., Knuuti, J., The adrenergic-fatty acid load in heart failure. J. Am. Coll. Cardiol. 54 (2009), 1637–1646.
4. [4] Ashrafian, H., Frenneaux, M.P., Opie, L.H., Metabolic mechanisms in heart failure. Circulation 116 (2007), 434–448.
5. [5] Lopaschuk, G.D., Ussher, J.R., Folmes, C.D., et al. Myocardial fatty acid metabolism in health and disease. Physiol. Rev. 90 (2010), 207–258.
6. [6] Nickel, A., Loffler, J., Maack, C., Myocardial energetics in heart failure. Basic Res. Cardiol., 108, 2013, 358.
7. [7] Schugar, R.C., Moll, A.R., Andre d'Avignon, D., et al. Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling. Mol. Metab. 3 (2014), 754–769.
8. [8] Newman, J.C., Verdin, E., beta-hydroxybutyrate: much more than a metabolite. Diabetes Res. Clin. Pract. 106 (2014), 173–181.
9. [9] Newman, J.C., Verdin, E., Ketone bodies as signaling metabolites. Trends Endocrinol. Metab. 25 (2014), 42–52.
10. [10] Shimazu, T., Hirschey, M.D., Newman, J., et al. Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339 (2013), 211–214.
11. [11] Nakajima, H., Ishida, T., Hirata, K., et al. Endothelial lipase modulates pressure overload-induced heart failure through alternative pathway for fatty acid uptake. Hypertension 61 (2013), 1002–1007.
12. [12] Toh, R., Kawashima, S., Yokoyama, M., et al. Transplantation of cardiotrophin-1-expressing myoblasts to the left ventricular wall alleviates the transition from compensatory hypertrophy to congestive heart failure in Dahl salt-sensitive hypertensive rats. J. Am. Coll. Cardiol. 43 (2004), 2337–2347.
13. [13] Tanaka, K., Sasayama, T., Irino, Y., et al. Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment. J. Clin. Investig. 125 (2015), 1591–1602.
14. [14] Satomi-Kobayashi, S., Ueyama, T., Takai, Y., et al. Deficiency of nectin-2 leads to cardiac fibrosis and dysfunction under chronic pressure overload. Hypertension 54 (2009), 825–831.
15. [15] Hara, T., Ishida, T., Hirata, K., et al. Endothelial cell-selective adhesion molecule regulates albuminuria in diabetic nephropathy. Microvasc. Res. 77 (2009), 348–355.
16. [16] Dai, D.F., Hsieh, E.J., Liu, Y., et al. Mitochondrial proteome remodelling in pressure overload-induced heart failure: the role of mitochondrial oxidative stress. Cardiovasc Res. 93 (2012), 79–88.
17. [17] Nho, R.S., Hergert, P., FoxO3a and disease progression. World J. Biol. Chem. 5 (2014), 346–354.
18. [18] Kops, G.J., Dansen, T.B., Polderman, P.E., et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419 (2002), 316–321.
19. [19] Nemoto, S., Finkel, T., Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 295 (2002), 2450–2452.
20. [20] Kupari, M., Lommi, J., Ventila, M., Karjalainen, U., Breath acetone in congestive heart failure. Am. J. Cardiol. 76 (1995), 1076–1078.
21. [21] Balietti, M., Fattoretti, P., Giorgetti, B., et al. A ketogenic diet increases succinic dehydrogenase activity in aging cardiomyocytes. Ann. N. Y. Acad. Sci. 1171 (2009), 377–384.
22. [22] Squires, J.E., Sun, J., Caffrey, J.L., et al. Acetoacetate augments beta-adrenergic inotropism of stunned myocardium by an antioxidant mechanism. Am. J. Physiol. Heart Circ. Physiol. 284 (2003), H1340–H1347.
23. [23] Zou, Z., Sasaguri, S., Rajesh, K.G., Suzuki, R., dl-3-Hydroxybutyrate administration prevents myocardial damage after coronary occlusion in rat hearts. Am. J. Physiol. Heart Circ. Physiol. 283 (2002), H1968–H1974.
24. [24] Fukao, T., Song, X.Q., Mitchell, G.A., et al. Enzymes of ketone body utilization in human tissues: protein and messenger RNA levels of succinyl-coenzyme A (CoA):3-ketoacid CoA transferase and mitochondrial and cytosolic acetoacetyl-CoA thiolases. Pediatr. Res. 42 (1997), 498–502.
25. [25] Henry, C.G., Strauss, A.W., Keating, J.P., Hillman, R.E., Congestive cardiomyopathy associated with beta-ketothiolase deficiency. J. Pediatr. 99 (1981), 754–757.
26. [26] Saudubray, J.M., Specola, N., Middleton, B., et al. Hyperketotic states due to inherited defects of ketolysis. Enzyme 38 (1987), 80–90.
27. [27] Kashiwaya, Y., Takeshima, T., Mori, N., et al. D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 5440–5444.
28. [28] Neal, E.G., Chaffe, H., Schwartz, R.H., et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 7 (2008), 500–506.
29. [29] Lutas, A., Yellen, G., The ketogenic diet: metabolic influences on brain excitability and epilepsy. Trends Neurosci. 36 (2013), 32–40.
30. [30] Rahman, M., Muhammad, S., Khan, M.A., et al. The beta-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages. Nat. Commun., 5, 2014, 3944.
31. [31] Youm, Y.H., Nguyen, K.Y., Grant, R.W., et al. The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat. Med. 21 (2015), 263–269.
32. [32] Aubert, G., Martin, O.J., Horton, J.L., et al. The failing heart relies on ketone bodies as a fuel. Circulation 133 (2016), 698–705.
33. [33] Bedi, K.C. Jr., Snyder, N.W., Brandimarto, J., et al. Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure. Circulation 133 (2016), 706–716.
34. [34] Yan, J., Young, M.E., Cui, L., et al. Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity. Circulation 119 (2009), 2818–2828.
35. [35] Chutoam, P., Charoensawan, V., Wongtrakoongate, P., et al. RpoS and oxidative stress conditions regulate succinyl-CoA: 3-ketoacid-coenzyme A transferase (SCOT) expression in Burkholderia pseudomallei. Microbiol. Immunol. 57 (2013), 605–615.